Changes in Retinal Cell Populations after Treatment with an α7 Nicotinic Acetylcholine Receptor Agonist by Flow Cytometry

被引：0
|
作者：
Vanzo-Sparks, Hope [1 ]
Webster, Sarah [2 ]
Linn, Cindy [1 ]
机构：
[1] Western Michigan Univ, Biol Sci, Kalamazoo, MI USA
[2] Western Michigan Univ, Homer Stryker MD Sch Med, Kalamazoo, MI USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5458
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Concise Synthesis of JN403, a Novel Nicotinic Acetylcholine Receptor 7 Selective Agonist
    Jiang, Xinglong
    Prasad, Kapa
    Repic, Oljan
    SYNTHETIC COMMUNICATIONS, 2009, 39 (15) : 2640 - 2646
  • [32] Synthesis and preliminary evaluation of a carbon-11-labelled agonist of the α7 nicotinic acetylcholine receptor
    Dolle, F
    Valette, H
    Hinnen, F
    Vaufrey, F
    Demphel, S
    Coulon, C
    Ottaviani, M
    Bottlaender, M
    Crouzel, C
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2001, 44 (11): : 785 - 795
  • [33] JN403, in vitro characterization of a novel nicotinic acetylcholine receptor α7 selective agonist
    Feuerbach, Dominik
    Nozulak, Joachim
    Lingenhoehl, Kurt
    McAllister, Kevin
    Hoyer, Daniel
    NEUROSCIENCE LETTERS, 2007, 416 (01) : 61 - 65
  • [34] A role for Leu118 of loop E in agonist binding to the α7 nicotinic acetylcholine receptor
    Amiri, Shiva
    Shimomura, Masaru
    Vijayan, Ranjit
    Nishiwaki, Hisashi
    Akamatsu, Miki
    Matsuda, Kazuhiko
    Jones, Andrew K.
    Sansom, Mark S. P.
    Biggin, Philip C.
    Sattelle, David B.
    MOLECULAR PHARMACOLOGY, 2008, 73 (06) : 1659 - 1667
  • [35] Encenicline, an α7 Nicotinic Acetylcholine Receptor Partial Agonist, Reduces Immune Cell Infiltration in the Colon and Improves Experimental Colitis in Mice
    Salaga, M.
    Blomster, L. V.
    Piechota-Polanczyk, A.
    Zielinska, M.
    Jacenik, D.
    Cygankiewicz, A. I.
    Krajewska, W. M.
    Mikkelsen, J. D.
    Fichna, Jakub
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 356 (01): : 157 - 169
  • [36] The Alpha7 nicotinic acetylcholine receptor is target for the treatment of skin fibrosis
    Boehm, M.
    Stegemann, A.
    BRAIN BEHAVIOR AND IMMUNITY, 2019, 81 : 49 - 50
  • [37] The α7 Nicotinic Acetylcholine Receptor: A Promising Target for the Treatment of Fibrotic Skin Disorders
    Stegemann, Agatha
    Flis, Damian
    Ziolkowski, Wieslaw
    Distler, Joerg H. W.
    Steinbrink, Kerstin
    Boehm, Markus
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (12) : 2371 - 2379
  • [38] Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder
    Fleisher, Carl
    McGough, James
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (08) : 1157 - 1163
  • [39] Consequences of linker length alteration of the α7 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333
    Beinat, Corinne
    Banister, Samuel D.
    van Prehn, Saundra
    Doddareddy, Munikumar Reddy
    Hibbs, David
    Sako, Michael
    Chebib, Mary
    Thao Tran
    Al-Muhtasib, Nour
    Xiao, Yingxian
    Kassiou, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (07) : 2380 - 2384
  • [40] EFFECTS OF THE α7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST GTS-21 ON THE INNATE IMMUNE RESPONSE IN HUMANS
    Kox, Matthijs
    Pompe, Jan C.
    de Gouberville, Marije C. Gordinou
    van der Hoeven, Johannes G.
    Hoedemaekers, Cornelia W.
    Pickkers, Peter
    SHOCK, 2011, 36 (01): : 5 - 11
12345